Cannabis-based GW Pharma raising more Nasdaq cash
Cambridge UK life science company GW Pharmaceuticals is set to raise around $1 million new money with a sale of ordinary shares on the US technology market, Nasdaq.
The company, whose treatments are cannabis based, says the amount it wants to raise is undecided. But its stock on Nasdaq is currently edging downwards towards its lowest on the market so GW would be happy to raise anything north of $1million.
It plans to issue 1.25 million American Depositary Shares in an underwritten US public offering. From an opening price of123.22, GW’s shares fell 5.77 cents on last trading to 115.23 – dangerously close to the low of 114.22 and well distanced from the high of 123.22.
Morgan Stanley, BofA Merrill Lynch and Cowen and Company are acting as joint book-running managers for the offering. Piper Jaffray & Co. is acting as lead manager.
The company has not given any reason for...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.